Sector
PharmaceuticalsOpen
₹2,015Prev. Close
₹1,995Turnover(Lac.)
₹32.95Day's High
₹2,031Day's Low
₹1,99552 Week's High
₹2,834.7552 Week's Low
₹1,530Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
1,176.69P/E
70.02EPS
28.52Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 1.47 | 1.09 | 1 | 0.01 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 80.59 | 18.05 | 5.58 | 3.13 |
Net Worth | 82.06 | 19.14 | 6.58 | 3.14 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Particulars (Rupees in Crores.) | Mar-2024 |
---|---|
Gross Sales | 212.5 |
Excise Duty | 0 |
Net Sales | 212.5 |
Other Operating Income | 0 |
Other Income | 5.4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,788.8 | 136.25 | 4,29,217.03 | 1,181.05 | 0.75 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,924.5 | 75.78 | 1,57,100.32 | 594 | 0.51 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,533.7 | 26.61 | 1,23,852.12 | 1,438.15 | 0.85 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,332.4 | 61.86 | 1,12,844.49 | 485 | 0.84 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,545.5 | 54.3 | 1,05,003.3 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
No Record Found
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Remus Pharmaceuticals Ltd
Summary
Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a Private to Public and the name of the Company was changed to Remus Pharmaceuticals Limited on January 06, 2023 by the Registrar of Companies, Ahmedabad.The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet. The core business of the Company into three categories, which comprise of Manufacturing, through loan licencse or on contract manufacturing bassis, of approved finished formulations and distribution of the same in various countries; Trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers.The product portfolio comprises of therapeutic drugs like ACE inhibitors, anaesthetic, Anti histamine, Antifungal, Anti-infla
Read More
The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1997.1 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd is ₹1176.69 Cr. as of 23 Apr ‘25
The PE and PB ratios of Remus Pharmaceuticals Ltd is 70.02 and 14.34 as of 23 Apr ‘25
The 52-week high/low is the highest and lowest price at which a Remus Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Remus Pharmaceuticals Ltd is ₹1530 and ₹2834.75 as of 23 Apr ‘25
Remus Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 15.58%, 6 Month at -19.53%, 3 Month at -5.60% and 1 Month at -8.07%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.